SAN RAFAEL, Calif.

,

Jan. 26, 2021

/PRNewswire/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on

Thursday, February 25

, at

4:30 p.m. ET

to discuss fourth quarter and full year 2020 financial results and provide a general business update.

Dial-in Number


U.S. / Canada Dial-in Number: (866) 502-9859

International Dial-in Number: (574) 990-1362

Conference ID: 6488682

Replay Dial-in Number: (855) 859-2056

Replay International Dial-in Number: (404) 537-3406

Conference ID: 6488682

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website,

www.biomarin.com

. A replay of the call will be archived on the site for one week following the call.

About BioMarin


BioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare genetic diseases. The company’s portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.  For additional information, please visit

www.biomarin.com

. Information on BioMarin’s website is not incorporated by reference into this press release.

View original content to download multimedia:

http://www.prnewswire.com/news-releases/biomarin-to-host-fourth-quarter-and-full-year-2020-financial-results-conference-call-and-webcast-on-thursday-february-25-at-430pm-et-301214639.html

SOURCE BioMarin Pharmaceutical Inc.